






Recent Progress in High-Performance Liquid Chromatographic 
Analysis of a Drug and its Metabolites 
-Direct Injection of Biological Samplesー
J un Haginaka 
Summary 
Recent progress in a high-performance liquid chromatographic method has been 
described for the assay of a drug and its metabolites in biological fluids. The m巴thods
using a proteinωcoated ODS silica， an internal surface reversed叩phasesilica and a size 
exclusion polymer as a stationary phase， and a micellar solution as an eluent on a 
reversed-phase silica were discussed on dir巴ctinjection of biological samples onto a 
column together with their applications to the assay of a drug and its metabolites in 















































Fig. 1 Chromatographic behavior of p呈pain as a 
function of incubation time on the column2• Column， 
C4 bonded phase on 10-μm LiChrosphere SI 500; 
mobile phase A， 10 mM H3P04， pH 2.2; mobile phase 
B，日20/1-propanol， 55/45 (v/v)， in which the 
total H3P04 concentration is 10 mM; linear gradient 
from 5 to 85% mobile phasεB in 30 min ; flow rate， 
1 mL/ min ; sample， 20μL/mL papain in mobile 
phase A (40-60μg of sample); temperature， 5'C; 






































































Fig. 3 Chromatograms of methotrexate analysis'. 
Column， protein-coated ODS column (6αn x 4nnn， 20ω32 
μm) ; eluent A， phosphate saline (pH 7.4); eluent 
B， eluent A/acetonitrile (92/8， v/v); el附 1twas 
changed from A to B; flow rate， 1.5mL/ min， 
temperature， 30'C; detection， 310nm. Sample; A， 
human pl証sma(50μL) ; B， methotrexate (2.0μg/mL. 
50μL); C. human plasma spiked with methotrex在民
(2.0μg/mし 50μ し).Signals: 1， injection marker; 2， 
proteins and oth己rs 3， buffer ch品目g邑 drift ; 4， 
methotr邑xate.





























































は， 20mMの SOSを含むO.lMりん援金緩衝液 (pH4.4) 
合用いて分離を行った 上述の移動相条件の選択範関内
では， CCLをタンパク質成分から分離できないが，アニ
Fig. 4 Cutaway view of internal surface reversedω オン伎のイオン対試薬である SOSを加えた酸性の移動
phase (lSRP). support particulate.17ω protein， (o) 相を用いることにより， CCLは，血液成分から分離され
analyte， (c) hydrophilic glycerylpropyl bonded external る.一方，血液タンパク質は， SOSにより可溶化される
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Fig. 6 Separation of cefaclor (CCL) from human 
serum." Mobile phase， 0.1 M sodium phosphate buff号r
(pH 4.38) containing 20mM SDS ; flowrate， 0.8mL/ 
min; st証tionary phase， ISRP (GFFS5-80); column， 
25c剖X 4.6限 ;d官民ction，254nm， injection， 10μL of (.心
















い.しかし，カラムの寿命を長くするためには，ガード Fig. 7 Chromatogram of (.刈blanks邑rumand但)serum 
カラム〔同じ闘定相を充事ました短いカラム(1 cm x 3 with (1) 2.5μg/mL ac邑taminophen，(2) 15μg/mL 
側 )Jを分析カラムの夜前に連絡することが望ましい phenobarbital，and (3) 10μg/mL chloramphenicol，" 
血液試料 00μ .Q) を 100~500四校入後，ガ…ドカラム Chromatographic conditions were as follows: column I 
を新しいものと取り替えることにより分離カラムは(TableI); mobile phase， 0.02 M SDS adjust吋 topH 
















































































'Column 1 ，15c田x4.6m毘 i.d.packed with 5μm Supelcosil LC心N (Supelco， Inc.); column n， 15cm x 4.6mm i.d. 
packed with 5μm Supelcosil LC -18 (Supelco， Inc.); column 翻， 25c田x4.6mm i.d. pack日dwith μBondap註 C-18 

























観測された. 2) 1 ~1O%牛血液アルブミン (BSA) 中




















ピンカートンカラムでは，移動相の pHは， 6.0~7.5 
が推奨されていたが，この方法では，逆相系のカラムで








































































Fig. 8 Chromatograms of cefmenoxime (CMX) and 
cefotiam (CTM) in distilled water (A)， in a serum 
sample (B) and in the acidified serum sample (0)." 
Column， Nucleosil 5C18 (15c田x4.6mm); eluent， 80mM 
SDS plus 45mM NaH2P04 and 5mM H3P04 -2-prop旦nol
(92: 8， v/v) (final pH 3.1); flow rate， 1.0mL/min; 
detection， 260nm， injection volume， 10μ L. Concentra舟
























Fig. 9 Flow diagram of HPLC drug analysis with 
automatic sample preparation.3! 1， eluent for pretreat笥
ment ; 2， eluent for analysis; 3， solvεnt switching 
valv邑;4， pump for pretreatment ; 5， pump for analysis 
; 6， auto sampler; 7， column switching valve; 8， 
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Fig. 10 Chromatogram of anticonvulsant drugs.3I 
Pretreatment column， TSKpr号column BSA-ODS ; 
eluent， 50mM phosphate buff告r(pH 7.0); flow rate， 
1.0mL/min; analytical column， TSKgel120 T; eluent， 
17% CH3CN in 50mM phosphate buffer (pH 7.0) 
0-15min， 22% CH3CN in 50mM phosphate buffer (pH 
7.0) 15“20min， 27% CH3CN in 50mM phosphate buffer 
(pH 7.0) 20-35min;flow rate， 1.0mL/min;detection， 
220nm ; sample， 1 = primidone (10μg/mL)，2=pheno-
barbital (20μg/mL)， 3 = carbamazepine (10μg/ 
mL)， 4口 phenytoin( 20μg/mL) ; injection volume， 
20μL; pretr邑atmenttime， 10min， flow dir邑ctionfrom 
pretreatment to an呂lyticalcolumn， reversed direction; 
conjunction time of pretreatment column and analytical 
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